Philip Low's most recent trade in Quince Therapeutics Inc was a trade of 455,309 Common Stock done . Disclosure was reported to the exchange on May 19, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Quince Therapeutics Inc | Philip Low | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2022 | 455,309 | 455,309 (1%) | 1% | - | Common Stock | |
| Quince Therapeutics Inc | Philip Low | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2022 | 63,974 | 63,974 (0%) | 0% | - | Common Stock | |
| Quince Therapeutics Inc | Philip Low | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2022 | 22,058 | 22,058 | - | - | Stock Option (right to buy) |